RxDoctor Payments Data

Yong Luo

Allergy · Flushing, NYNPI 1902130628

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 313 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Sanofi at 32.0% of the total. 2025 is the largest year on record at $4,014, 8.5 times the $472 reported in 2019.

$11,103in general payments, 2019–2025

Across 313 payments — averaging $35.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$4K
  • GSK$2K
  • Regeneron Healthcare Solutions, Inc.$1K
  • AstraZeneca$1K
  • Amgen$424
  • Axsome Therapeutics, Inc.$375
  • plus $3K from 24 others

What the payments were for

  • Food & beverage$10,73397%
  • Education$3693%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,103 in reported general payments places this provider in the 75th percentile of 92 allergy providers in New York.

See all allergy providers in New York

Medicare billing

Part B allowed, 2024
$29,271
Medicare patients
23
Services billed
1,785

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab51$187,971
Clemastine Fumarate13$30,512
Tacrolimus39$7,766
Mometasone Furoate87$3,034
Azelastine Hcl175$2,483
Halobetasol Propionate29$2,099
Bepotastine Besilate11$1,570
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$1,453
Fluticasone Propionate154$1,397
Clobetasol Propionate19$799
Triamcinolone Acetonide30$419
Ipratropium Bromide17$405
Montelukast Sodium48$185
Hydrocortisone18$112
Famotidine12$62

Paid to pharmacies, not to this prescriber.

Other allergy in Flushing

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →